NADAC acquisition cost data for CIPRO 10% SUSPENSION. This is a brand-name medication — generic alternatives may be available at lower prices.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 50419077301 | $1.46 | 2022-01-19 | Rx |
| 50419077301 | $1.46 | 2022-01-19 | Rx |
| 50419077301 | $1.46 | 2022-01-19 | Rx |
| 50419077301 | $1.46 | 2022-01-19 | Rx |
| 50419077301 | $1.46 | 2022-01-19 | Rx |
| 50419077301 | $1.46 | 2022-01-19 | Rx |
| 50419077301 | $1.46 | 2022-01-19 | Rx |
| 50419077301 | $1.46 | 2022-01-19 | Rx |
| 50419077301 | $1.46 | 2022-01-19 | Rx |
| 50419077301 | $1.46 | 2022-01-19 | Rx |
Generic: Ciprofloxacin | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $375.8K | 2,059 | 1,635 | $1.48 |
| 2020 | $394.6K | 2,197 | 1,772 | $1.49 |
| 2021 | $415.8K | 2,268 | 1,789 | $1.49 |
| 2022 | $387.6K | 2,153 | 1,798 | $1.51 |
| 2023 | $396.4K | 2,217 | 1,810 | $1.51 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| California | $47.0K | 241 | 203 |
| New York | $38.0K | 221 | 157 |
| Texas | $33.0K | 193 | 167 |
| Florida | $27.7K | 154 | 128 |
| Ohio | $23.0K | 122 | 97 |
| Pennsylvania | $14.9K | 83 | 76 |
| Michigan | $14.7K | 82 | 72 |
| Illinois | $13.9K | 75 | 70 |
| Georgia | $11.9K | 72 | 61 |
| New Jersey | $11.4K | 67 | 55 |
| Indiana | $11.3K | 64 | 57 |
| Alabama | $10.5K | 56 | 33 |
| North Carolina | $9.5K | 58 | 55 |
| Connecticut | $9.1K | 50 | 43 |
| Kentucky | $8.9K | 53 | 34 |
| Wisconsin | $8.8K | 32 | 18 |
| Missouri | $8.7K | 44 | 40 |
| Arizona | $7.6K | 45 | 40 |
| South Carolina | $7.1K | 43 | 37 |
| Virginia | $6.6K | 41 | 37 |
| Maryland | $6.4K | 34 | 25 |
| Tennessee | $6.0K | 35 | 33 |
| New York | $6.0K | 47 | 23 |
| Louisiana | $5.3K | 31 | 26 |
| Massachusetts | $5.3K | 33 | 29 |
| Minnesota | $5.2K | 26 | 23 |
| Florida | $4.7K | 35 | 31 |
| Colorado | $3.6K | 20 | 18 |
| Washington | $3.5K | 19 | 14 |
| California | $3.3K | 48 | 32 |
| Iowa | $3.2K | 16 | N/A |
| Kansas | $3.1K | 19 | N/A |
| Oklahoma | $2.8K | 14 | 13 |
| Connecticut | $2.4K | 16 | N/A |
| Mississippi | $2.3K | 12 | N/A |
| West Virginia | $2.3K | 18 | 14 |
| Oregon | $2.2K | 12 | 12 |
| Arkansas | $2.0K | 12 | 11 |
| Maine | $1.8K | 12 | 11 |
| Pennsylvania | $1.3K | 18 | N/A |
| Ohio | $1.1K | 12 | N/A |
| Texas | $910.96 | 11 | 11 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.